Jan 27, 2020 | 340B, News and Updates
On January 27, 2020, the Governmental Accountability Office (GAO) released a report on the Medicaid 340B Drug Discount Program, particularly how the 340B program intersects with the Medicaid Drug Rebate Program. The GAO argued that a lack of transparency and...
Jan 8, 2020 | 340B, News and Updates
On January 8, 2020, the Centers for Medicare and Medicaid (CMS) issued an informational bulletin outlining a series of best practices for states to consider for avoiding duplicate discounts in the 340B program. According to CMS, the guidance is in response to...
Apr 1, 2019 | 340B, News and Updates
On April 1, 2019, the Health Resources and Services Administration implemented its long-delayed final rule on 340B ceiling price transparency, releasing a database reporting the maximum price drug manufacturers may charge covered entities for 340B drugs. Several...
Dec 27, 2018 | 340B, Litigation, News and Updates
On December 27, 2018, the United States District Court for the District of Columbia granted plaintiff hospitals’ motion to permanently enjoin HHS’ nearly 30% cut to certain 340B drugs. The Court held that in implementing its Medicare Part B rate reduction, the Agency...
Dec 10, 2018 | 340B, News and Updates, Rulemaking
On November 29, 2018, the Health Resources and Services Administration (HRSA) confirmed the effective date of its final rule on the 340B Drug Pricing Program. The rule institutes new ceiling prices on 340B drugs and authorizes monetary penalties against drug...
Nov 1, 2018 | 340B, News and Updates, Rulemaking
Facing a legal challenge from the hospital industry, the Health Resources and Services Administration has proposed a January 1, 2019 effective date of a rule to establish a system to verify ceiling prices for 340B drugs, to provide web site access to the ceiling...
